A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
NCT03116412 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1300
Last updated 2024-12-16
Summary
It is not known whether radiological assessments during follow up after surgery for high risk melanoma improve survival. Since radiological examinations are resource demanding, could inflict worry and cause irradiation exposure it is an important question to address. With the introduction of effective medical treatments for malignant melanoma patients, there is a tendency to introduce radiological assessments despite the lack of evidence.
Conditions
- Malignant Melanoma
Interventions
- PROCEDURE
-
CT or PET scans
Scans and blood tests are scheduled at baseline, months 6, 12, 24 and 36.
Sponsors & Collaborators
-
Uppsala University
lead OTHER
Principal Investigators
-
Gustav Ullenhag, associate professor · Uppsala University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-08
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
NCT05645484 ·Status: UNKNOWN
-
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NCT06835426 ·Status: RECRUITING ·Phase: NA
-
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
NCT00316901 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FLT PET Imaging in Patients With Advanced Melanoma
NCT02891616 ·Status: TERMINATED ·Phase: PHASE1
-
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
NCT00351728 ·Status: COMPLETED
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
MPDL3280A-treatment-IST-UMCG
NCT02478099 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
NCT04747561 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
NCT06199713 ·Status: RECRUITING
-
Early FDG PET in Melanoma
NCT02716077 ·Status: TERMINATED ·Phase: NA
-
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103 ·Status: ENROLLING_BY_INVITATION
-
[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
NCT05801159 ·Status: COMPLETED
-
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
NCT02317393 ·Status: COMPLETED ·Phase: PHASE2
-
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer
NCT03311672 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
NCT04333524 ·Status: ACTIVE_NOT_RECRUITING
-
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
NCT04272658 ·Status: RECRUITING
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
NCT03051542 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Response by FLT PET in Mesothelioma
NCT06410625 ·Status: RECRUITING ·Phase: NA
-
Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers
NCT07114172 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
NCT06232122 ·Status: RECRUITING ·Phase: NA